RELN and multiple sclerosis: The ability to selectively modulate Reelin levels in the periphery opens avenues for exploring its therapeutic potential in diseases characterized by compromised endothelial function, such as atherosclerosis, multiple sclerosis, and even severe inflammatory conditions like COVID-19.